socastcmsRssStart88.7 myFM News staffsocastcmsRssEnd 
MediPharm Labs Corp. has announced the sale of its Napanee facility to Kensana Health Inc. in a $5.5 million deal, as part of a strategic move to streamline operations. Kensana Health will acquire MediPharm’s subsidiary, ABcann Medicinals, which includes the facility’s license, building, land, and equipment. The agreement also establishes a partnership between the companies, leveraging MediPh…

93.3 myFM

MediPharm Labs sells Napanee facility for $5.5M

Green Stock News for the New Green Economy.

Green Stock News

MediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5M

MediPharm Labs has reached an agreement to sell its Napanee facility to Kensana Health for $5.5 million. Kensana Health will acquire the licence of the Napanee facility as well as the building, land, and equipment while current commercial agreements and activities of the company will stay with MediPharm Labs. The two companies will also form a strategic partnership including a comprehensive supply and services agreement that will see Kensana Hea…

Quinte News

MediPharm labs selling Napanee facility

Canadian cannabinoid company MediPharm Labs is selling its manufacturing operation in Ontario for $5.5 million to Kensana Health. Under terms of the cash deal, Ontario-based Kensana Health will acquire all of the issued and outstanding shares of MediPharm subsidiary ABcann Medicinals, according to a Tuesday release.   ADVERTISEMENT    Once the transaction is finalized, Kensana also will acquire a business license as well as the building, land and

Marijuana Business Daily

MediPharm inks deal to sell Ontario cannabis operation for $5.5 million

Canadian cannabinoid company MediPharm Labs is selling its manufacturing operation in Ontario for $5.5 million to Kensana Health. MediPharm inks deal to sell Ontario cannabis operation for $5.5 million is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

newsbudz.com

Kensana wants to use the facility to develop an FDA-approved topical chronic wound treatment. The post MediPharm Labs sells Ontario facility for C$5.5M as part of streamlining plan appeared first on Green Market Report.

Cannabis News World

MediPharm Labs sells Ontario facility for C$5.5M as part of streamlining plan - Cannabis News World

Kensana Health has agreed to acquire all of the issued and outstanding shares in the capital of ABcann from the company's operating subsidiary MediPharm Labs... The post MediPharm plans to sell ABcann facility to Kensana Health in cash deal appeared first on StratCann.

StratCann

MediPharm plans to sell ABcann facility to Kensana Health in cash deal

TORONTO — MediPharm Labs Corp. and Kensana Health Inc. announce that they have entered into a share purchase agreement for the purchase and sale of MediPharm’s facility in Napanee, Ontario through a disposition of all of the Company’s indirect equity interests in its wholly-owned subsidiary ABcann Medicinals Inc. to Kensana Health for $5.5 million in cash. Pursuant to the Purchase Agreement, Kensana Health has agreed to acquire all of the issued…

MediPharm Labs sells Napanee facility for $5.5M

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics